Treatment Of Patients With Social Anxiety Disorder

Completed · Phase 2

Conditions studied: Social Phobia

In brief

GW876008 is a drug which may change mans reaction to stress, by decreasing the fear, physical and behavior symptoms that people with SocAD experience in social situations.

Key facts

Study ID

NCT00397722

Run by

GlaxoSmithKline

People needed

299

Starts

2006-11-09

Expected to finish

2007-09-05

Last updated by the study team

2017-07-11

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• are diagnosed with generalized social anxiety disorder/social phobia.

You may not qualify if…

• have a diagnosis of major depressive disorder
• have a history of Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder.

Where it is running

• GSK Investigational Site — Beverly Hills, California, United States
• GSK Investigational Site — Burbank, California, United States
• GSK Investigational Site — Temecula, California, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Orlando, Florida, United States
• GSK Investigational Site — Smyrna, Georgia, United States
• GSK Investigational Site — Oakbrook Terrace, Illinois, United States
• GSK Investigational Site — Rockville, Maryland, United States
• GSK Investigational Site — Farmington Hills, Michigan, United States
• GSK Investigational Site — Nutley, New Jersey, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — Media, Pennsylvania, United States
• GSK Investigational Site — Edmonton, Alberta, Canada
• GSK Investigational Site — Kelowna, British Columbia, Canada
• GSK Investigational Site — Miramichi, New Brunswick, Canada
• GSK Investigational Site — Mississauga, Ontario, Canada
• GSK Investigational Site — Kuopio, Finland
• GSK Investigational Site — Rauma, Finland
• GSK Investigational Site — Turku, Finland
• GSK Investigational Site — Hüttenberg, Hesse, Germany
• GSK Investigational Site — Achim, Lower Saxony, Germany
• GSK Investigational Site — Göttingen, Lower Saxony, Germany
• GSK Investigational Site — Westerstede, Lower Saxony, Germany
• GSK Investigational Site — Berlin, Germany
• GSK Investigational Site — Hamar, Norway

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.